Eventide Asset Management »

Fifth Third Ban shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Fifth Third Ban (FITB) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Fifth Third Ban

Tip: Access up to 7 years of quarterly data

All positions including Fifth Third Ban held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fifth Third Ban by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $903k 20k 45.40
2025-06-30 $4.1M 93k 44.33

More positions owned by Eventide Asset Management

Guardant Health (GH)
Mirum Pharmaceuticals (MIRM)
Xometry Class A Com (XMTR)
Trane Technologies SHS (TT)
Insmed Com Par $.01 (INSM)
Lam Research Corp Com New (LRCX)
Irhythm Technologies (IRTC)
Ge Vernova (GEV)
Scholar Rock Hldg Corp (SRRK)
Beta Bionics (BBNX)
Argenx Se Sponsored Adr (ARGX)
Roper Industries (ROP)
Vistra Energy (VST)
Axsome Therapeutics (AXSM)
Toast Cl A (TOST)

View all positions for Eventide Asset Management

Top funds holding Fifth Third Ban

Vanguard Group
BlackRock
State Street Corporation
Capital World Investors
Jpmorgan Chase & Co
Charles Schwab Investment Management
Invesco
Geode Capital Management
Morgan Stanley
Nuveen
Dimensional Fund Advisors
Allspring Global Investments Holdings
Franklin Resources
Robeco Investment Management
Northern Trust

View all funds holding Fifth Third Ban